ArticleCEN case reports2025

Nephrotic syndrome after switching from irinotecan, S-1, and bevacizumab combination to trifluridine/tipiracil.

Jun Takami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.